A recent meta-analysis encompassing 25 studies by Nian et al. demonstrated that methylated SEPT9 (Epi ProColon; Epigenomics AG) serves as a reliable blood-based biomarker for colorectal cancer detection, particularly showing high efficacy in identifying advanced-stage tumors [140]. Here, SEPTIN9 is linked to colorectal cancer.